Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost Ocular Insert vs Timolol in Glaucoma/OHT
NCT01915940Phase 2Completed
- Sponsor
- ForSight VISION5
- Start
- Oct 2013
- Primary completion
- Sep 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bimatoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by ForSight VISION5. Started Oct 2013; status: completed.
02
Drugs
bimatoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01915940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01915940.